The store will not work correctly when cookies are disabled.
4-(3,3-dimethylbutanoyl)-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one
ID: ALA2287737
PubChem CID: 76334650
Max Phase: Preclinical
Molecular Formula: C23H30O3
Molecular Weight: 354.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(C)c(C2=C(C(=O)CC(C)(C)C)C3(CCCC3)OC2=O)c(C)c1
Standard InChI: InChI=1S/C23H30O3/c1-14-11-15(2)18(16(3)12-14)19-20(17(24)13-22(4,5)6)23(26-21(19)25)9-7-8-10-23/h11-12H,7-10,13H2,1-6H3
Standard InChI Key: FYNUIOVGICLBAE-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
5.4340 -21.0271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1878 -20.7104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1194 -19.8956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3234 -19.7088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8999 -20.4082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5174 -21.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5163 -22.0252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2243 -22.4342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9340 -22.0247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9311 -21.2021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2225 -20.7968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2201 -19.9796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8082 -22.4332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6423 -22.4322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -20.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4081 -21.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4308 -19.7363 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6495 -19.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9961 -19.4847 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6453 -21.8404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4285 -22.6255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4624 -21.8301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8798 -22.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6970 -22.5224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4802 -23.2454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2816 -23.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
11 12 1 0
7 13 1 0
9 14 1 0
10 15 1 0
15 16 2 0
16 5 1 0
5 17 1 0
17 18 1 0
18 15 1 0
18 19 2 0
16 20 1 0
20 21 2 0
20 22 1 0
22 23 1 0
23 24 1 0
23 25 1 0
23 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.49 | Molecular Weight (Monoisotopic): 354.2195 | AlogP: 5.24 | #Rotatable Bonds: 3 |
Polar Surface Area: 43.37 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 6.52 | CX LogD: 6.52 |
Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.70 | Np Likeness Score: 0.09 |
References
1. Zhao JH, Wang ZC, Ji MH, Cheng JL, Zhu GN, Yu CM.. (2012) Synthesis and bioactivity evaluation of novel spiromesifen derivatives., 68 (1): [PMID:21997953] [10.1002/ps.2248] |